Eir Partners invests in ClaimsBridge, supports add-on of DialysisPPO
- ClaimsBridge validates the accuracy of medical, dental and institutional claims to reduce unnecessary costs.
- DialysisPPO helps healthcare insurance plans save on Medicare spending for dialysis care immediately.
Eirs Partners has announced an investment in ClaimsBridge, a provider of technology services for helping third-party administrators, networks and employers manage medical, dental and institutional claims.
The investment was made alongside ClaimBridge’s acquisition of DialysisPPO, a cost containment services provider that specializes in cases of end-stage renal disease (ESRD) and chronic dialysis treatment.
ClaimsBridge is based in Arnold, Maryland, and helps TPAs, self-funded employers and healthcare insurance networks validate the integrity of claims and reduce prices and process complexity.
DialysisPPO is headquartered in Malvern, Pennsylvania, and helps healthcare insurance plans save on Medicare spending for dialysis care immediately. It bypasses the thirty-month coordination period typically required.
The deal gives ClaimsBridge clients direct access to specialized, patented products and services for one of the highest-cost chronic conditions.
“Our investment is about scaling that platform faster, organically and through acquisitions like DialysisPPO,” said Brett Carlson, CEO and founder of Eir Partners, in a statement.
